CatequentinibHypertension and hand-foot syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1826卷 / 1期

关键词：

D O I：

10.1007/s40278-020-84538-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[41] RivoceranibExacerbated proteinuria, thrombocytopenia and hand-foot syndrome: case report
Reactions Weekly, 2021, 1885 (1) : 464 - 464
[42] Trastuzumab emtansineCarotenoderma (first report) with hand-foot syndrome: case report
Reactions Weekly, 2015, 1554 (1) : 182 - 182
[43] Capecitabine/trastuzumabDrug resistance and hand-foot syndrome: case report
Reactions Weekly, 2021, 1884 (1) : 115 - 115
[44] Apatinib/gemcitabine/paclitaxelThrombocytopenia and hand-foot syndrome: case report
Reactions Weekly, 2017, 1682 (1) : 47 - 47
[45] SunitinibFatigue, hand-foot syndrome, leucopenia and thrombocytopenia: case report
Reactions Weekly, 2016, 1583 (1) : 1006 - 1006
[46] A rare unilateral expression of hand-foot syndrome: a case report
Portillo, Daniela Urueta
Lathrop, Kate
CANCER RESEARCH, 2024, 84 (09)
[47] Alcohol/doxorubicinHand-foot syndrome and exacerbation of hand-foot syndrome: case report
Reactions Weekly, 2021, 1836 (1) : 33 - 33
[48] Panitumumab/regorafenibBullous pemphigoid and hand-foot syndrome: case report
Reactions Weekly, 2016, 1595 (1) : 164 - 164
[49] AntineoplasticsNeutropenic fevers, mucositis and hand-foot syndrome: case report
Reactions Weekly, 2019, 1739 (1) : 38 - 38
[50] Docetaxel/gemcitabineDermatomyositis associated with hand-foot syndrome: case report
Reactions Weekly, 2021, 1846 (1) : 109 - 109

← 1 2 3 4 5 →